Cargando…
LncRNA XIST acts as a MicroRNA-520 sponge to regulate the Cisplatin resistance in NSCLC cells by mediating BAX through CeRNA network
Background: In recent years, LncRNA acts as a member of competing endogenous RNA (ceRNA), playing an important role in drug resistance of lung cancer. The aim of this study was to identify potential biomarkers about cisplatin resistant lung cancer cells using a comprehensive ceRNA network. Methods:...
Autores principales: | Liu, Ting-Ting, Li, Rui, Liu, Xiao, Zhou, Xi-Jia, Huo, Chen, Li, Jian-Ping, Qu, Yi-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757131/ https://www.ncbi.nlm.nih.gov/pubmed/33390811 http://dx.doi.org/10.7150/ijms.49730 |
Ejemplares similares
-
Identification and functional analysis of LncRNA-XIST ceRNA network in prostate cancer
por: Wang, Jie, et al.
Publicado: (2022) -
lncRNA-mediated ceRNA network in bladder cancer
por: Li, Kun, et al.
Publicado: (2022) -
The regulatory mechanism of LncRNA-mediated ceRNA network in osteosarcoma
por: Lin, Chengsen, et al.
Publicado: (2022) -
The ceRNA network of lncRNA and miRNA in lung cancer
por: Seo, Danbi, et al.
Publicado: (2020) -
LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting as ceRNA to Sponge miR-520a-3p and Upregulate MAPK1 Expression
por: Wu, Qingwei, et al.
Publicado: (2021)